CID to Update Interventional Cardiologists on Their Drug Eluting Stent Program at TCT 2010

WASHINGTON,, September 16, 2010 - CID s.r.l., a European company leader in interventional medicine, will
update interventional cardiologists on the status of their revolutionary drug
eluting stent technology during The Drug Eluting Stent (DES) Summit at TCT
2010, Washington, DC on Wednesday, September 22, 2010. The lecture, entitled
"Status of the CID Cre8 polymer-free DES program", will be delivered by
Alexandre Abizaid, MD, PhD. Chief of Intervention at Instituto Dante
Pazzanese, in Sao Paulo Brazil, and will be part of the session "The Next
Generation DES, Polymer-Free".

Some of the highlights of the presentation will include an exploration of
the clinical benefits of CID's Abluminal Reservoir Technology (ART) and drug
delivery technology. By surrounding molecules of drug with amphiphilic
carriers and embedding them into reservoirs on the stent's outer surface, CID
drug-eluting stents are able to deliver drug to the coronary arteries without
using any polymers, which can cause serious complications in patients.

CID's unique ART system with its amphiphilic carrier is more
physiological and patients who receive these stents are less likely to have
inflammation and thrombosis within their coronary arteries. Moreover CID DES
technology features an integral Bio-Inducer Surface (BIS) which implies less
medication to prevent blood clotting after the stent has been deployed for
enhanced safety.

Commenting on the innovative technology in its new Cre8 DES, Franco
Vallana, Chief Executive Officer of CID s.r.l. said, "We have always known
that the more the stent and the drug delivery system are designed and
developed to harmonize with the human body, the better the short- and
long-term results will be. Combining ART with our innovative drug formulation
with amphiphilic carrier into a completely polymer-free stent will allow
doctors to provide their patients with stents that are more physiological and
complement the body's natural systems."

Info at cidvascular.com, www.cidvascular.com, +39-0161-487338